A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

BACKGROUND: To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer. METHODS: We tested the sensitizing effects of ROS elevating drugs to cisplatin (cDDP) in ovarian cancer both in vitro and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chaoyang, Guo, Ensong, Zhou, Bo, Shan, Wanying, Huang, Jia, Weng, Danhui, Wu, Peng, Wang, Changyu, Wang, Shixuan, Zhang, Wei, Gao, Qinglei, Xu, Xiaoyan, Wang, Beibei, Hu, Junbo, Ma, Ding, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839150/
https://www.ncbi.nlm.nih.gov/pubmed/31703584
http://dx.doi.org/10.1186/s12885-019-6288-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839150/
https://www.ncbi.nlm.nih.gov/pubmed/31703584
http://dx.doi.org/10.1186/s12885-019-6288-7

Ejemplares similares